Skip to main content
. 2021 Feb 1;7:630480. doi: 10.3389/fcvm.2020.630480

Figure 7.

Figure 7

Sunitinib and imatinib treatments both cause increased mitochondrial superoxide production in cardiac fibroblasts. (Ai) Histogram showing superoxide production assessed via fluorescence intensity in antimycin A and vehicle treated CFs (Aii) Representative images of MitoSOX Red analysis of antimycin A and vehicle treated samples. (Bi) Superoxide production assessed via fluorescence intensity in sunitinib treated CFs (Bii) Representative images of MitoSOX Red analysis of sunitinib treated samples. (Ci) Superoxide production assessed via fluorescence intensity in imatinib treated CFs (Cii) Representative images of MitoSOX Red analysis of imatinib treated samples. Scale bar 100 μm. Results shown are mean data from one experiment (n = 10), representative of two other experiments (*p < 0.05).